Metropolis Healthcare Limited

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E. Other stock markets 23:00:00 15/07/2024 BST			5-day change	1st Jan Change
2,040 ^INR	-1.61%		-0.37%	+21.59%

07-09	Metropolis Healthcare Clocks 13% Increase in Fiscal Q1 Overall Revenue	MT
07-09	Metropolis Healthcare Limited Announces Consolidated Revenue Results for the First Quarter Ended June 30, 2024	CI

Metropolis Healthcare Limited Announces Consolidated Revenue Results for the First Quarter Ended June 30, 2024

July 09, 2024 at 07:12 am

Metropolis Healthcare Limited announced Consolidated revenue results for the first quarter ended June 30, 2024. For the period, revenues grew by 13% on year on year basis. B2C revenues grew at 18% year on year.

Latest news about Metropolis Healthcare Limited

Metropolis Healthcare Clocks 13% Increase in Fiscal Q1 Overall Revenue	07-09	MT
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the First Quarter Ended June 30, 2024	07-09	CI
Metropolis Healthcare Limited to Seek Acquisitions	05-22	CI
Transcript : Metropolis Healthcare Limited, Q4 2024 Earnings Call, May 22, 2024	05-22
Metropolis Healthcare Limited Appoints Sushil Shah as Chairman Emeritus, Effective May 22, 2024	05-21	CI
Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-21	CI
Metropolis Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-21	CI
Metropolis Healthcare Limited Receives Notice from the Anti-Corruption Branch, New Delhi	05-12	CI
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	05-10	RE
Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue	04-11	MT
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024	04-10	CI
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3	02-05	MT
Transcript : Metropolis Healthcare Limited, Q3 2024 Earnings Call, Feb 05, 2024	02-05
Metropolis Healthcare Limited Announces Management Changes	02-02	CI
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-02	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	02-01	RE
Transcript : Metropolis Healthcare Limited, Q2 2024 Earnings Call, Nov 06, 2023	11-06
Metropolis Healthcare Limited Approves and Declares Payment of an Interim Dividend for the Financial Year 2023-24	11-04	CI
Crisil Keeps AA- Rating on Metropolis Healthcare's Bank Loans; Revises Outlook to Stable	05/10/23	MT
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023	06/09/23	CI
Metropolis Healthcare Limited Appoints Mohan Menon as Chief Marketing Officer	07/08/23	CI
Metropolis Healthcare's Consolidated Profit Drops in Fiscal Q1	04/08/23	MT
Metropolis Healthcare to Seek Smaller Bolt-On Acquisitions	03/08/23	CI
Transcript : Metropolis Healthcare Limited, Q1 2024 Earnings Call, Aug 03, 2023	03/08/23
Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02/08/23	CI

Chart Metropolis Healthcare Limited

Duration

Period

More charts

Company Profile

Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.

Sector

Healthcare Facilities & Services

Calendar

06/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Metropolis Healthcare Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,040 INR

Average target price

1,933 INR

Spread / Average Target

-5.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
METROPOLIS HEALTHCARE LIMITED	+21.59%	1.25B
SONIC HEALTHCARE LIMITED	-16.72%	8.48B
RADNET, INC.	+87.40%	4.81B
DR. LAL PATHLABS LIMITED	+16.31%	2.99B
SYNLAB AG	-3.15%	2.65B
NEOGENOMICS, INC.	-2.10%	2.02B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-53.27%	1.87B
FLEURY S.A.	-12.97%	1.58B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-47.96%	1.06B
OPKO HEALTH, INC.	-4.64%	1B

Medical & Diagnostic Laboratories